Our Members

The following people participate in our network by contributing their time and expertise to be members of our advisory board, committees and working groups. Their guidance helps ensure that the OHTN conducts and supports the most innovative and scientifically rigorous HIV research with the potential to improve the health and well-being of people with HIV in Ontario.  We thank them for their contribution.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z


R


Janet Raboud
Dr. Janet Raboud has a PhD in biostatistics and is an Associate Professor in the Dalla Lana School of Public Health Sciences at the University of Toronto and an Affiliate Scientist in the Division of Infectious Diseases at the University Health Network. She has been involved in collaborative research in HIV for many years, both in clinical research and in epidemiology and has over 100 published papers in peer-reviewed journals. She currently holds a Career Scientist Award from the Ontario HIV Treatment Network (2005-2014) and is involved in the Ontario Cohort Study as a member of the Scientific Review Committee, Clinical Working Group and Data Working Group and is Principal Investigator or co-investigator on a number of OCS protocols.
Anita Rachlis
Dr. Rachlis is Professor, Department of Medicine, Division of Infectious Diseases, University of Toronto, ON. She has worked in HIV/AIDS care since 1983 at Sunnybrook Health Sciences Centre and has been involved in clinical research in the treatment of opportunistic infections and antiretroviral therapy. She received a Council Award in February 2002 from the College of Physicians and Surgeons of Ontario for her work in the care and treatment of HIV patients. She facilitated the development of the Canadian HIV/AIDS Primary Care Physician Mentorship Program (CHAMP) and the HIV Ontario Observational Database (HOOD) which was the forerunner of the Ontario Cohort Study (OCS). Dr. Rachlis is a member of the Board of Directors of the Ontario HIV Treatment Network (OHTN); participates in the Canadian HIV Trials Network; and serves as a scientific reviewer for granting agencies. She has been a member of the Ontario Advisory Committee on HIV/AIDS since 1991, co chair since 2009 and member of the Ministerial Advisory Council on the Federal Initiative to Address HIV/AIDS in Canada since September 2003.
Mark Ragan
Mark Ragan (1966-2010) will be dearly missed by all members of the OHTN staff. Mark contributed to the OHTN as an active member of the senior management team for two years, from 2008 to 2010. During this time, he excelled and established himself as a leader in the organization. Initially hired as Manager of the Knowledge Translation and Exchange program, he was soon promoted to Director of Operations and Administration in recognition of his talents in organizational issues and management. Mark was always one of the first in the office and the last to leave, and was instrumental in supporting all of the important work in which the OHTN engages. Mark held a high bar for excellence and innovation, and expected this from himself, and all members of his team and the OHTN staff. He was very adept at managing but also was a big picture thinker and saw what directions the OHTN needed to take to fulfill its mission and make a difference. The OHTN is deeply saddened by his passing, but will remember fondly his positive, optimistic and effective leadership style, and his spirit will continue to enrich the work of the OHTN.
Charles Rinaldo
Charles Rinaldo
Dr. Rinaldo is Chairman and Professor of Infectious Diseases and Microbiology (IDM) in the University of Pittsburgh Graduate School of Public Health (GSPH) and Professor of Pathology in the School of Medicine. Dr. Rinaldo has a distinguished background in several areas of basic research and clinical diagnostics, as well as in research administration. Dr. Rinaldo's research is focused on the relation of disease progression to dendritic cell function and reactivity of CD8 killer T cells to HIV and human herpesvirus 8 (HHV-8, or KSHV, the cause of Kaposi’s sarcoma). Recent research has expanded to dendritic cell-T cell interactions in hepatitis C virus infection, and in emerging virus infections including West Nile virus, dengue virus and influenza A virus.
Stanley Read
Dr. Stanley Read is a Pediatric Infectious Diseases specialist at the Hospital for Sick Children and a Professor of Pediatrics and Pathobiology and Laboratory Medicine at the University of Toronto. He has been Director of the Family Centered HIV/AIDS Program at the Hospital for Sick Children since it was started in 1988. He has served on many Canadian and Ontario HIV/AIDS advisory committees. Dr. Read's research interests are in the diagnosis and management of children with HIV and reduction of maternal-to-child transmission. He is Consultant in Child and Adolescent Health to the Ministry of Health in the Bahamas and Director of Clinical Research and Laboratory Services.
Robert Remis
Robert Remis
Dr. Remis has worked in the field of HIV surveillance and epidemiologic research for more than 25 years. Robert is a Professor at the Dalla Lana School of Public Health, University of Toronto. He helps monitor the HIV epidemic in Ontario under a mandate of the AIDS Bureau, Ontario Ministry of Health and Long-Term Care. In this capacity, he has published over 15 technical and situation reports that have been used extensively for HIV prevention policy, program development and research.

Dr. Remis has published more than 60 peer-reviewed articles. He has worked extensively as a consultant for Health Canada, the Krever Commission and the Ontario Hepatitis C Secretariat, primarily on the modelling of HIV infection and viral hepatitis in Canada and has also consulted internationally in the field of HIV and communicable disease surveillance. He has been an active participant in the Canadian Association of HIV/AIDS Research (CAHR), the African-Caribbean Council on HIV/AIDS in Ontario (ACCHO) and the Research Advisory Committee of the OHTN.
Ron Rosenes
Ron Rosenes
Ron Rosenes has been an active member of the HIV/AIDS community in Toronto since 1991. He is currently Vice Chair of the Canadian Treatment Action Council, Chair of the OHTN Community Network Advisory Committee and member of the OHTN Scientific Review Committee. Ron previously served as Board Chair of the AIDS Committee of Toronto. He has worked on the steering committee of the Canada AIDS Russia Program and is a member of AIDS Action Now! Ron was also a member of the AIDS 2006 Toronto Local Host Board.
Ken Rosenthal
Dr. Rosenthal is Professor and Director of Molecular Medicine in the Department of Pathology and Molecular Medicine and Head of the Virus Vaccines Division of the Centre for Gene Therapeutics at McMaster University. His research is focused on understanding the role of innate and adaptive mucosal immunity against chronic viral infections and development of safe and effective mucosal vaccines and therapeutics to protect against mucosally/sexually-transmitted viruses, including herpes simplex virus type 2 (HSV-2) and HIV/AIDS.
Sean Rourke
Sean Rourke
Dr. Sean B. Rourke completed his PhD in 1995 in Clinical Psychology with a specialization in Clinical Neuropsychology at the University of California, San Diego. Sean is the Scientific and Executive Director of the OHTN since 2004. He is also the Director of Research in the Mental Health Service and Scientist with the Centre for Research on Inner City Health Centre in The Keenan Research Centre in the Li Ka Shing Knowledge Institute of St. Michael's Hospital at St. Michael’s Hospital, an Associate Professor in the Department of Psychiatry and a Full Graduate Member of the Institute of Medical Science at the University of Toronto, and an Adjunct Professor in the Department of Psychology at the University of Windsor. Sean has also served as a member of the OHTN Scientific Review Committee and Board of Directors and received an OHTN Career Scientist Award for his work developing a neurobehavioural program of research in HIV/AIDS before joining the OHTN as its Director. In 2005, he received a New Researcher Award from the Ontario Ministry of Research and Innovation.
Sergio Rueda
Sergio Rueda
Sergio Rueda is Associate Scientist and Director of Population Health at the Ontario HIV Treatment Network. In this role, he is providing leadership to ensure the OHTN meets its goals of supporting policy-relevant population health research and related knowledge translation strategies within the social determinants of health framework. Sergio is leading the development of a population health research program that situates labour force participation, working conditions and income security as fundamental determinants of health. This program of research uses a variety of methodologies to study the health effects of employment transitions, including longitudinal cohort studies, secondary analyses of existing datasets, and systematic reviews.

DID YOU
KNOW

At the OHTN, our role is to help answer key questions: Why, What if, and What will make a difference?

FOLLOW
THE OHTN